SC 13D/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 19)

CLINICAL DATA, INC.

(Name of Issuer)

COMMON STOCK, $.01 par value per share

(Title of Class of Securities)

18725U109

(CUSIP Number)

Third Security, LLC

The Governor Tyler

1881 Grove Avenue

Radford, Virginia 24141

Attention: Marcus E. Smith, Esq.

Telephone No.: 540-633-7971

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

Copy to:

John Owen Gwathmey, Esq.

Troutman Sanders LLP

Troutman Sanders Building

1001 Haxall Point

Richmond, Virginia 23219

February 26, 2007

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement

on Schedule 13G to report the acquisition which is the

subject of this Schedule 13D, and is filing this

schedule because of Rules 13d-1(e), (f) or (g),

check the following box o.

Page 1 of 10 Pages

CUSIP No. 18725U109 13D Page 2 of 10 Pages 

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Randal J. Kirk
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x
3.	SEC USE ONLY
4.	SOURCE OF FUNDS PF
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) o
6.	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ______________	7.	SOLE VOTING POWER 1,066,191
	8.	SHARED VOTING POWER 2,961,665
	9.	SOLE DISPOSITIVE POWER 1,066,191
	10.	SHARED DISPOSITIVE POWER 2,961,665
11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,028,656
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 41.3%
14.	TYPE OF REPORTING PERSON IN

CUSIP No. 18725U109 13D Page 3 of 10 Pages 

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) RJK, L.L.C.   I.R.S. Identification No.: 54-1816015
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x
3.	SEC USE ONLY
4.	SOURCE OF FUNDS WC
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) o
6.	CITIZENSHIP OR PLACE OF ORGANIZATION Virginia
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ______________	7.	SOLE VOTING POWER 0
	8.	SHARED VOTING POWER 731,083
	9.	SOLE DISPOSITIVE POWER 0
	10.	SHARED DISPOSITIVE POWER 731,083
11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 731,083
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.5%
14.	TYPE OF REPORTING PERSON OO - limited liability company

CUSIP No. 18725U109 13D Page 4 of 10 Pages 

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) New River Management II, LP   I.R.S. Identification No.: 65-1166473
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x
3.	SEC USE ONLY
4.	SOURCE OF FUNDS WC
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) o
6.	CITIZENSHIP OR PLACE OF ORGANIZATION Virginia
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ______________	7.	SOLE VOTING POWER 0
	8.	SHARED VOTING POWER 699,918
	9.	SOLE DISPOSITIVE POWER 0
	10.	SHARED DISPOSITIVE POWER 699,918
11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 699,918
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.2%
14.	TYPE OF REPORTING PERSON OO - limited partnership

CUSIP No. 18725U109 13D Page 5 of 10 Pages 

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kirkfield, L.L.C.   I.R.S. Identification No.: 54-1725089
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x
3.	SEC USE ONLY
4.	SOURCE OF FUNDS WC
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) o
6.	CITIZENSHIP OR PLACE OF ORGANIZATION Virginia
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ______________	7.	SOLE VOTING POWER 0
	8.	SHARED VOTING POWER 680,504
	9.	SOLE DISPOSITIVE POWER 0
	10.	SHARED DISPOSITIVE POWER 680,504
11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 680,504
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.0%
14.	TYPE OF REPORTING PERSON OO - limited liability company

This Amendment No. 19 (the “Amendment”) amends and supplements the Statement on Schedule 13D, dated November 26, 1999 and filed on December 6, 1999, as amended by Amendment No. 1 dated March 10, 2000 and filed on March 15, 2000, Amendment No. 2 dated June 8, 2000 and filed on June 9, 2000, Amendment No. 3 dated December 31, 2000 and filed on January 8, 2001, Amendment No. 4 dated February 7, 2001 and filed on March 1, 2001, Amendment No. 5 dated June 6, 2001 and filed on June 8, 2001, Amendment No. 6 dated June 25, 2001 and filed on June 26, 2001, Amendment No. 7 dated September 6, 2001 and filed on September 7, 2001, Amendment No. 8 dated October 23, 2001 and filed on October 26, 2001, Amendment No. 9 dated October 26, 2001 and filed on October 30, 2001, Amendment No. 10 dated August 21, 2002 and filed on August 21, 2002, Amendment No. 11 dated April 29, 2003 and filed on May 2, 2003, Amendment No. 12 dated November 10, 2003 and filed on November 14, 2003, Amendment No. 13 dated June 20, 2005 and filed on June 27, 2005, Amendment No. 14 dated November 17, 2005 and filed on November 23, 2005, Amendment No. 15 dated February 9, 2006 and filed on February 15, 2006, Amendment No. 16 dated May 18, 2006 and filed on May 23, 2006, Amendment No. 17 dated June 13, 2006 and filed on June 15, 2006, and Amendment No. 18 dated September 13, 2006 and filed on September 22, 2006 (as amended, the “Original Schedule 13D”), relating to the Common Stock, par value $.01 per share (the “Common Stock”), of Clinical Data, Inc., a Delaware corporation (the “Issuer”). Mr. Randal J. Kirk (“Mr. Kirk”), RJK, L.L.C., a Virginia limited liability company that is controlled by Mr. Kirk (“RJK”), New River Management II, LP, a Virginia limited partnership that is controlled by Mr. Kirk (“NRM II”), and Kirkfield, L.L.C., a Virginia limited liability company that is controlled by Mr. Kirk (“Kirkfield” and, together with Mr. Kirk, RJK and NRM II, the “Reporting Persons”), are filing this Amendment to disclose the acquisition by RJK, Kirkfield, Third Security Staff 2001 LLC, a Virginia limited liability company that is controlled by Mr. Kirk (“Staff LLC”), NRM II, New River Management III, LP, a Virginia limited partnership that is controlled by Mr. Kirk (“NRM III”), and Zhong Mei, L.L.C., a Virginia limited liability company that is controlled by Mr. Kirk (“Zhong Mei”), of an aggregate of 184,360 shares of Common Stock through the exercise of warrants received in connection with the purchase of Common Stock by such entities in a private placement by the Issuer in June 2006. As described in this Amendment, some of the Common Stock that is beneficially owned by Mr. Kirk is directly beneficially owned by one of the following entities, each of which is controlled by Mr. Kirk: RJK, Kirkfield, Staff LLC, NRM II, NRM III, Zhong Mei, and Radford Investment Limited Partnership, a Delaware limited partnership (“Radford”).

Except as set forth below, there are no changes to the information set forth in the Original Schedule 13D.

Item 3. Source and Amount of Funds or Other Consideration.

Item 3 of the Original Schedule 13D is hereby amended and supplemented as follows:

“On February 26, 2007, RJK, Kirkfield, Staff LLC, NRM II, NRM III and Zhong Mei invested approximately $980,280, $732,682, $619,152, $938,501, $259,249 and $55,938, respectively, of cash on hand to purchase an aggregate of 184,360 shares of Common Stock through the exercise of warrants received in connection with the purchase of Common Stock by such entities in a private placement by the Issuer in June 2006. The exercise price of these warrants was $19.45 per share.”

Page 6 of 10 Pages

Item 5. Interest in Securities of the Issuer.

Item 5(a) of the Original Schedule 13D is hereby amended and restated to read in its entirety as follows:

“The aggregate number and percentage of shares of Common Stock to which this statement relates is 4,028,656 shares, representing 41.3% of the 9,754,745 shares outstanding as of the date of this report, based upon the number of shares disclosed by the Issuer as of February 13, 2007 in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2006 (the most recent available filing by the Issuer with the Securities and Exchange Commission). Mr. Kirk directly beneficially owns 1,066,991 of the shares to which this report relates. The remaining 2,961,665 shares of Common Stock to which this statement relates are directly beneficially owned as follows:

Owner	Shares
Kirkfield	680,504
RJK	731,083
Zhong Mei	41,719
NRM II	699,918
NRM III	193,343
Radford	153,353
Staff LLC	461,745

Mr. Kirk could be deemed to have indirect beneficial ownership of the shares directly beneficially owned by Kirkfield, RJK, Zhong Mei, NRM II, NRM III, Radford and Staff LLC.”

Item 5(c) of the Original Schedule 13D is hereby amended and supplemented as follows:

“Other than the purchase of Common Stock through the exercise of warrants issued in the private placement as reported herein and the issuance of shares of Common Stock in connection with Mr. Kirk’s service to the Issuer as the Chairman of the Board, the Reporting Persons have not engaged in any transactions in shares of Common Stock since the filing of Amendment No. 18 with the Securities and Exchange Commission on September 22, 2006.”

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

Item 6 of the Original Schedule 13D is hereby amended and supplemented as follows:

“In connection with the purchase in the private placement of Common Stock by RJK, Kirkfield, Staff LLC, NRM II, NRM III and Zhong Mei, the Issuer issued 50,400, 37,670, 31,833, 48,252, 13,329 and 2,876 warrants, respectively, to RJK, Kirkfield, Staff LLC, NRM II, NRM III and Zhong Mei. The exercise price of the warrants was $19.45, equaling a twenty percent premium on the closing bid price of the Common Stock on the Nasdaq Stock Market on June 13, 2006, the closing date of the private placement. Upon issuance, the warrants were to be exercisable at any time six months after June 13, 2006 through the close of business on the fifth year anniversary of the date on which the warrants initially become exercisable. Except as otherwise described in this statement, to the best knowledge of any of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2, or between such persons and any other person, with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.”

Page 7 of 10 Pages

Item 7. Material to be Filed as Exhibits.

The following documents are being filed as exhibits to this Amendment and are incorporated herein by reference:

Exhibit 99.1 Joint Filing Agreement, dated as of February 27, 2007, by and among Randal J. Kirk, RJK, L.L.C., New River Management II, LP and Kirkfield, L.L.C.

Page 8 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Date: February 27, 2007	/s/ Randal J. Kirk
	Randal J. Kirk
Date: February 27, 2007	RJK, L.L.C.
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Manager
Date: February 27, 2007	NEW RIVER MANAGEMENT II, LP
	By:	Third Security Capital Partners, LLC, its general partner
	By:	Third Security, LLC, its managing member
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Sole Member
Date: February 27, 2007	KIRKFIELD, L.L.C.
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Manager

Page 9 of 10 Pages

EXHIBIT INDEX

Exhibit Number	Exhibit
Exhibit 99.1	Joint Filing Agreement, dated as of February 27, 2007, by and among Randal J. Kirk, RJK, L.L.C., New River Management II, LP and Kirkfield, L.L.C.

Page 10 of 10 Pages

EX-99.1

EXHIBIT 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons names below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Clinical Data, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 27th day of February, 2007.

Date: February 27, 2007	/s/ Randal J. Kirk
	Randal J. Kirk
Date: February 27, 2007	RJK, L.L.C.
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Manager
Date: February 27, 2007	NEW RIVER MANAGEMENT II, LP
	By:	Third Security Capital Partners, LLC, its general partner
	By:	Third Security, LLC, its managing member
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Manager
Date: February 27, 2007	KIRKFIELD, L.L.C.
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Manager